All In Biotech

Drug Trial Radar · NCT02785185

Safety and Efficacy of IDP-122 Lotion When Applied Topically to Subjects With Moderate to Severe Plaque Psoriasis

A Phase 2, Multi-Center, Double-Blind, Randomized, Vehicle-Controlled Study to Compare the Safety and Efficacy of IDP-122 Lotion (0.01% Halobetasol Propionate) to Ultravate® (Halobetasol Propionate) Cream, in the Treatment of Plaque Psoriasis

Last checked: Nov 20, 2026Latest source record: Aug 27, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 150 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

150

Actual

Start

Jun 2016

Primary completion

Dec 2, 2016

Study completion Jan 2017

Sponsor

Lead sponsor
Bausch Health Americas, Inc.Industry
Sponsor type
Industry
First posted
May 27, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

A Phase 2, Multi-Center, Double-Blind, Randomized, Vehicle-Controlled Study.

Conditions

  • Psoriasis

Interventions

  • IDP-122 Vehicle LotionDrug

    Vehicle

  • IDP-122 Vehicle CreamDrug

    Vehicle

  • IDP-122 LotionDrug

    Lotion

  • Ultravate CreamDrug

    Cream

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants With Treatment Success of a 2-Grade IGA Score Improvement From Baseline and an IGA Score of Clear or Almost Clear at Week 2Time frame: 2 weeks

Locations

13 sites in 1 country. Site status is shown where the registry gives one.

  • Valeant Site 05

    Rogers, Arkansas

  • Valeant Site 10

    Beverly Hills, California

  • Valeant Site 09

    Carlsbad, California

  • Valeant Site 13

    Los Angeles, California

  • Valeant Site 12

    Santa Monica, California

  • Valeant Site 07

    Coral Gables, Florida

  • Valeant Site 11

    North Miami Beach, Florida

  • Valeant Site 03

    Sanford, Florida

  • Valeant Site 08

    Albany, Indiana

  • Valeant Site 04

    Louisville, Kentucky

  • Valeant Site 06

    Fridley, Minnesota

  • Valeant Site 02

    High Point, North Carolina

  • Valeant Site 01

    Houston, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.